AHA: TR Flashcards
regurgitant jet width (% of RA) in mild TR
not specified in either AHA or ASE
%
vena contracta in mild TR
<0.3
cm; only specified in ASE
RVol/Vregurg in mild TR
regurgitant volume
<30
mL/beat; only specified in ASE
RF in mild TR
regurgitant fraction
NO RF for TR specified in either AHA or ASE
%
EROA in mild TR
effective regurgitant orifice area
<0.2
cm2; only specified in ASE
grade in mild TR
NO grade for TR specified in either AHA or ASE
hep vein flow reversal in mild TR
systolic dominance
only specified in ASE
regurgitant jet width (% of RA) in moderate TR
not specified in either AHA or ASE
%
vena contracta in moderate TR
0.3-0.7
cm; only specified in ASE
RVol/Vregurg in moderate TR
regurgitant volume
30-45
mL/beat; only specified in ASE
RF in moderate TR
regurgitant fraction
NO RF for TR specified in either AHA or ASE
%
EROA in moderate TR
effective regurgitant orifice area
0.2-0.4
cm2; only specified in ASE
grade in moderate TR
NO grade for TR specified in either AHA or ASE
hep vein flow reversal in moderate TR
systolic blunting
only specified in ASE
regurgitant jet width (% of RA) in severe TR
≥50
%
vena contracta in severe TR
≥0.7
cm
RVol/Vregurg in severe TR
regurgitant volume
≥45
mL/beat
RF in severe TR
regurgitant fraction
NO RF for TR specified in either AHA or ASE
%
EROA in severe TR
effective regurgitant orifice area
≥0.4
cm2
grade in severe TR
NO grade for TR specified in either AHA or ASE
hep vein flow reversal in severe TR
systolic
tricuspid valve
vena contracta <0.3 cm
mild TR
tricuspid valve
RVol/Vregurg <30 mL/beat
regurgitant volume
mild TR
tricuspid valve
EROA <0.2 cm2
effective regurgitant orifice area
mild TR
tricuspid valve
vena contracta = 0.3-0.7 cm
moderate TR
tricuspid valve
RVol/Vregurg = 30-45 mL/beat
regurgitant volume
moderate TR
tricuspid valve
EROA = 0.2-0.4 cm2
effective regurgitant orifice area
moderate TR
tricuspid valve
regurgitant jet width (% of RA) ≥50 %
severe TR
tricuspid valve
vena contracta ≥0.7 cm
severe TR
tricuspid valve
RVol/Vregurg ≥45 mL/beat
regurgitant volume
severe TR
tricuspid valve
EROA ≥0.4 cm2
effective regurgitant orifice area
severe TR
Is degenerative or rheumatic TR more common?
neither
~50/50
indication(s) for intervention in moderate TR
- progressive + concomitant <3 L valve surg + annulus EDD>40mm regardless of sx status OR prior RH fail sxs (2a)
” In patients with progressive TR (Stage B) undergoing left-sided valve surgery, tricuspid valve surgery can be beneficial in the context of either 1) tricuspid annular dilation (tricuspid annulus end diastolic diameter >4.0 cm) or 2) prior signs and symptoms of right-sided HF.”
indication(s) for intervention in moderate TR
(1)
- progressive + concomitant <3 L valve surg + annulus EDD>40mm regardless of sx status OR prior RH fail sxs (2a)
” In patients with progressive TR (Stage B) undergoing left-sided valve surgery, tricuspid valve surgery can be beneficial in the context of either 1) tricuspid annular dilation (tricuspid annulus end diastolic diameter >4.0 cm) or 2) prior signs and symptoms of right-sided HF.”
indication(s) for intervention in asx severe TR
- concomitant <3 L valve surg (1)
regardless of sx status - progressive + concomitant <3 L valve surg + annulus EDD>40mm regardless of sx status OR prior RH fail sxs (2a)
- progressive RV dil or systolic dysfxn (2b)
- “In patients with severe TR (Stages C and D) undergoing left-sided valve surgery, tricuspid valve surgery is recommended.”
- “In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In patients with signs and symptoms of right-sided HF and severe isolated secondary TR attributable to annular dilation (in the absence of pulmonary hypertension or left-sided disease) who are poorly responsive to medical therapy (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In asymptomatic patients with severe primary TR (Stage C) and progressive RV dilation or systolic dysfunction, isolated tricuspid valve surgery may be considered.” (2b)
- “In patients with signs and symptoms of right-sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery may be considered in the absence of severe pulmonary hypertension or severe RV systolic dysfunction.” (2b)
indication(s) for intervention in asx severe TR
(3)
- concomitant <3 L valve surg (1)
regardless of sx status - progressive + concomitant <3 L valve surg + annulus EDD>40mm regardless of sx status OR prior RH fail sxs (2a)
- progressive RV dil or systolic dysfxn (2b)
- “In patients with severe TR (Stages C and D) undergoing left-sided valve surgery, tricuspid valve surgery is recommended.”
- “In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In patients with signs and symptoms of right-sided HF and severe isolated secondary TR attributable to annular dilation (in the absence of pulmonary hypertension or left-sided disease) who are poorly responsive to medical therapy (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In asymptomatic patients with severe primary TR (Stage C) and progressive RV dilation or systolic dysfunction, isolated tricuspid valve surgery may be considered.” (2b)
- “In patients with signs and symptoms of right-sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery may be considered in the absence of severe pulmonary hypertension or severe RV systolic dysfunction.” (2b)
indication(s) for intervention in sx severe TR
- concomitant <3 L valve surg (1)
regardless of sx status - progressive + concomitant <3 L valve surg + annulus EDD>40mm regardless of sx status OR prior RH fail sxs (2a)
- RH fail + 1° TR (2a)
- RH fail + 2° TR 2/2 annular dil (+ ⊖pHTN/LH fail) + poor response to GDMT (2a)
- RH fail + h/o prior L valve surg (+ ⊖pHTN, ⊖severe RV systolic dysfxn) (2b)
- “In patients with severe TR (Stages C and D) undergoing left-sided valve surgery, tricuspid valve surgery is recommended.”
- “In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In patients with signs and symptoms of right-sided HF and severe isolated secondary TR attributable to annular dilation (in the absence of pulmonary hypertension or left-sided disease) who are poorly responsive to medical therapy (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In asymptomatic patients with severe primary TR (Stage C) and progressive RV dilation or systolic dysfunction, isolated tricuspid valve surgery may be considered.” (2b)
- “In patients with signs and symptoms of right-sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery may be considered in the absence of severe pulmonary hypertension or severe RV systolic dysfunction.” (2b)
indication(s) for intervention in sx severe TR
(5)
- concomitant <3 L valve surg (1)
regardless of sx status - progressive + concomitant <3 L valve surg + annulus EDD>40mm regardless of sx status OR prior RH fail sxs (2a)
- RH fail + 1° TR (2a)
- RH fail + 2° TR 2/2 annular dil (+ ⊖pHTN/LH fail) + poor response to GDMT (2a)
- RH fail + h/o prior L valve surg (+ ⊖pHTN, ⊖severe RV systolic dysfxn) (2b)
- “In patients with severe TR (Stages C and D) undergoing left-sided valve surgery, tricuspid valve surgery is recommended.”
- “In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In patients with signs and symptoms of right-sided HF and severe isolated secondary TR attributable to annular dilation (in the absence of pulmonary hypertension or left-sided disease) who are poorly responsive to medical therapy (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.” (2a)
- “In asymptomatic patients with severe primary TR (Stage C) and progressive RV dilation or systolic dysfunction, isolated tricuspid valve surgery may be considered.” (2b)
- “In patients with signs and symptoms of right-sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery may be considered in the absence of severe pulmonary hypertension or severe RV systolic dysfunction.” (2b)
triangle of Koch boundaries
(contains AVN)
- coronary sinus
- tendon of Todaro/Eustachian ridge
- TV annulus (septal leaflet)
triangle of Koch contents
AV node
Where & what structures are at risk around the tricuspid annulus?
- AVN @ base of septal leaflet (triangle of Koch)
- RCA @ anterior leaflet > posterior leaflet (if L-dominant)
- coronary sinus @ posterior leaflet
- ± aortic valve NCC @ anteroseptal commissure
- ± bundle of His @ septal leaflet / anteroseptal commissure